<DOC>
	<DOCNO>NCT01390857</DOCNO>
	<brief_summary>The purpose post-marketing surveillance study collect ass information safety efficacy valaciclovir pediatric patient chickenpox</brief_summary>
	<brief_title>Special Drug Use Investigation VALTREX ( Valaciclovir ) ( Pediatrics Chickenpox )</brief_title>
	<detailed_description />
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<criteria>Pediatric patient chickenpox ( age less 15 year old ) . Patients history hypersensitivity ingredient valaciclovir acyclovir .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>